Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yusuke Hada"'
Publikováno v:
Nihon Naika Gakkai Zasshi. 104:735-741
Autor:
Kazuo Hara, Takashi Kadowaki, Osamu Miyazaki, Atsushi Tsuchida, Hironori Waki, Yusuke Hada, Hirokazu Yago, Toshimasa Yamauchi, Hiroyuki Ebinuma
Publikováno v:
Biochemical and Biophysical Research Communications. 356:487-493
Adiponectin is an adipocyte-derived hormone and known to form several species of multimer, however, the precise components of each multimer have not been fully determined. We purified each multimer adiponectin selectively from human plasma and charac
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 104(4)
Autor:
Toshimasa Yamauchi, Sato Takekawa, Takashi Kadowaki, Atsushi Tsuchida, Toshiyuki Maki, Yusuke Hada, Yusuke Ito
Publikováno v:
Diabetes. 54:3358-3370
We examined the effects of activation of peroxisome proliferator-activated receptor (PPAR)alpha, PPARgamma, and both of them in combination in obese diabetic KKAy mice and investigated the mechanisms by which they improve insulin sensitivity. PPARalp
Autor:
Shunbun Kita, Junji Kamon, Toshimasa Yamauchi, S. Uchida, Satoshi Kimura, Takashi Kadowaki, Kazuo Hara, Yusuke Hada, Yusuke Ito, Ryozo Nagai, Philippe Froguel, Francis Vasseur, Hironori Waki
Publikováno v:
Journal of Biological Chemistry. 278:40352-40363
Adiponectin is an adipocyte-derived hormone, which has been shown to play important roles in the regulation of glucose and lipid metabolism. Eight mutations in human adiponectin have been reported, some of which were significantly related to diabetes
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 68(10)
Incretin, GIP and GLP-1, are blood glucose lowering hormones secreted from K cells and L cells, and are rapidly degenerated by DPP-4 within a few minutes. Recently incretin related drugs, GLP-1 analogs and DPP-4 inhibitors are developed. GLP-1 analog
Publikováno v:
The Proceedings of Conference of Chugoku-Shikoku Branch. :707-1
Autor:
Toshimasa Yamauchi, Yusuke Hada, Kazuo Hara, Naoto Kubota, Takashi Kadowaki, Takashi Miida, Hiroyuki Ebinuma
Publikováno v:
Clinical chemistry. 53(8)
Background: Human serum adiponectin exists in 3 multimer forms: high molecular weight (HMW), middle molecular weight, and low molecular weight (LMW), with some of the latter bound to albumin (Alb)-LMW. Some studies have suggested that adiponectin cro
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 64
Autor:
Takeshi Takazawa, Ryozo Nagai, Hitomi Ogata, Philippe Froguel, Masato Iwabu, Tomohiro Ide, Miki Okada-Iwabu, Tetsuya Kubota, Hideki Kozono, Kazuyuki Tobe, Iseki Takamoto, Yasunori Nio, Atsushi Tsuchida, Yusuke Hada, Masaki Tsunoda, Yusuke Ito, Junji Kamon, Kazuo Hara, Masaki Kobayashi, Toshiyuki Maki, Motoharu Awazawa, Kumpei Tokuyama, Kohjiro Ueki, Katsuyoshi Kumagai, Toshimasa Yamauchi, Naoto Kubota, Kouji Murakami, Sachiko Kawamoto, Takashi Kadowaki
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2007, 13 (3), pp.332-9. ⟨10.1038/nm1557⟩
Nature Medicine, 2007, 13 (3), pp.332-9. ⟨10.1038/nm1557⟩
Nature Medicine, Nature Publishing Group, 2007, 13 (3), pp.332-9. ⟨10.1038/nm1557⟩
Nature Medicine, 2007, 13 (3), pp.332-9. ⟨10.1038/nm1557⟩
Adiponectin plays a central role as an antidiabetic and antiatherogenic adipokine. AdipoR1 and AdipoR2 serve as receptors for adiponectin in vitro, and their reduction in obesity seems to be correlated with reduced adiponectin sensitivity. Here we sh